Immunogenicity and Safety of Homologous and Heterologous Booster Vaccination of ChAdOx1 nCoV-19 (COVISHIELD TM) and BBV152 (COVAXIN®) in Previous Recipients of COVISHIELD TM or COVAXIN®: A Phase 4, Participant and Observer Blinded, Randomised Study
SSRN Electronic Journal(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined